-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on HCA Healthcare, Raises Price Target to $525

Benzinga·10/27/2025 17:59:05
Listen to the news
UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $495 to $525.